Michigan 2023-2024 Regular Session

Michigan House Bill HB4619

Introduced
5/23/23  
Refer
5/23/23  
Report Pass
6/21/23  
Engrossed
6/28/23  
Refer
6/28/23  
Report Pass
9/28/23  
Refer
9/28/23  
Report Pass
10/5/23  
Enrolled
10/10/23  
Chaptered
10/19/23  

Caption

Insurance: insurers; denying coverage based on gender, gender identity, or sexual orientation or expression; prohibit. Amends sec. 2027 of 1956 PA 218 (MCL 500.2027).

Impact

The bill would modify existing legislation significantly, particularly affecting regulations related to how insurance companies assess risks and determine coverage. By addressing issues of cultural and social equity in coverage policies, the bill is positioned to improve the availability and affordability of insurance for marginalized groups, thereby aiming for a more equitable insurance landscape. Additionally, it introduces provisions for the establishment of a nonprofit malpractice insurance fund and addresses the affordability of automobile insurance and homeowners insurance, making it easier for all residents to secure necessary policies.

Summary

House Bill 4619 is an act intended to amend the existing laws surrounding the insurance and surety business in Michigan. Its primary objective is to prohibit discrimination in insurance coverage based on gender, gender identity, or sexual orientation. This aligns with broader efforts to ensure equal treatment and access to insurance services for all residents of the state, reflecting an ongoing commitment to inclusivity in insurance practices. The amendment to section 2027 of the Michigan Compiled Laws seeks to enact stricter rules against unfair methods of competition in the insurance market.

Sentiment

The overall sentiment around HB 4619 is generally positive among advocates for LGBTQ+ rights and those in favor of eliminating discrimination in insurance practices. Supporters argue that this legislation is a crucial step towards ensuring equitable access to essential services, reflecting a modern understanding of inclusivity. However, some concerns have been raised about the implications for insurance companies and how they might adapt to increased regulatory scrutiny, with foes worrying about the potential burdens placed on these entities.

Contention

Notable points of contention include the balance between ensuring fair practices and the operational freedom of insurance companies. While advocates champion the prohibition against discriminatory practices, there are concerns from some industry stakeholders regarding the possibility that stringent regulations may impede insurance companies' risk assessment capabilities. This raises questions about how insurance markets may be affected, especially in regard to pricing and coverage options, and could lead to debates about insurance viability in various sectors. Addressing these concerns will be crucial as the bill is enacted and implemented.

Companion Bills

No companion bills found.

Similar Bills

HI SB2030

Relating To Prescription Drugs.

NJ S326

Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."

NJ A3692

Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."

NJ S150

Requires physicians and other prescribers to obtain electronic or written consent for certain medications with "black box warnings."

AZ SB1164

Pharmacy benefits; coverage

MI HB5436

Health occupations: pharmacists; pharmacists to prescribe and dispense certain contraceptives; allow. Amends secs. 17703, 17704, 17707, 17708, 17709, 17744, 17751 & 17757 of 1978 PA 368 (MCL 333.17703 et seq.) & adds sec. 17744g.

MI HB4365

Health: pharmaceuticals; distribution of opioid antagonists by employees and agents of agencies under the administration of opioid antagonists act; provide for. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b). TIE BAR WITH: HB 4366'23

MI HB5078

Health: pharmaceuticals; distribution of opioid antagonists by employees and agents of agencies under the administration of opioid antagonists act; provide for. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).